Preprint · CC-BY
via OpenAlex
[Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease].
Yifeng Li, Guihong Chen, Meijun Chen, Yan Lin, Cheng Luo, Lingxin Guo, Wenbao Hu, Zhengzhao Liu
PubMed · 2025
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Cell culture / in vitro
Human
Abstract
Klotho (KL) protein is a key renoprotective protein that exerts organ-protective effects through regulation of mineral metabolism, anti-inflammatory and antioxidant activity, anti-aging signaling, modulation of autophagy(definition), and inhibition of fibrosis. KL levels decline from the early stage of chronic kidney disease (CKD) and are correlated with disease severity, indicating its strong potential as an early diagnostic biomarker. However, current KL-targeted therapies have not yet achieved clinical translation. Recent studies demonstrate that engineered fibroblast growth factor-23 (FGF-23) binding peptides show up to a 2 300-fold increase in affinity for KL, providing a basis for developing high-sensitivity KL assays. In parallel, persistent activation of endoplasmic reticulum (ER)-associated degradation (ERAD) may represent a major mechanism driving KL ubiquitination and degradation. The emerging deubiquitinase-targeting chimera (DUBTAC) technology protects target proteins from degradation by inhibiting their ubiquitination. The combination of engineered FGF-23 binding peptides and KL-targeted DUBTAC technology may accelerate clinical development of sensitive detection and targeted therapeutic strategies for KL, holding substantial clinical significance for CKD management.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.11817/j.issn.1672-7347.2025.250245
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Li, Y., Chen, G., Chen, M., Lin, Y., Luo, C., Guo, L., Hu, W., & Liu, Z. (2025). [Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease]. <em>PubMed</em>. https://doi.org/10.11817/j.issn.1672-7347.2025.250245
Vancouver
Li Y, Chen G, Chen M, Lin Y, Luo C, Guo L, et al. [Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease]. PubMed. 2025. doi:10.11817/j.issn.1672-7347.2025.250245.
BibTeX
@unpublished{yifeng2025Potent,
title = {[Potential of early diagnosis and targeted therapy for Klotho protein in chronic kidney disease].},
author = {Yifeng Li and Guihong Chen and Meijun Chen and Yan Lin and Cheng Luo and Lingxin Guo and Wenbao Hu and Zhengzhao Liu},
journal = {PubMed},
year = {2025},
doi = {10.11817/j.issn.1672-7347.2025.250245},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nephrology Dialysis Transplantation 2012
Open access · OA
The emerging role of Klotho in clinical nephrology
Springer eBooks 2016
Citation only
Vitamin D and Klotho in Chronic Kidney Disease
Frontiers in Endocrinology 2020
Open access · CC-BY
Klotho, Aging, and the Failing Kidney
International Urology and Nephrology 2016
Citation only
Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease
Molecular Biomedicine 2025
Open access · CC-BY
Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases
Cancers 2020
Open access · CC-BY